Additionally, some novel GLP-1s hold promise for improved tolerability, as evidenced by Structure Therapeutics phase 2 data for GSBR-1290, which demonstrated encouraging results in terms of AEs and discontinuation rates
Monitoring these values, especially at higher doses, is not optional, it is medically important
Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2
Early benefits may have been symptomatic, not disease-modifying In the initial trials, patients on exenatide ended with better MDS-UPDRS-3 motor scores than at baseline , a surprising finding for a disease-modifying drug
Heymsfield SB, Coleman LA, Miller R, Rooks DS, Laurent D, Petricoul O, Praestgaard J, Swan T, Wade T, Perry RG, Goodpaster BH, Roubenoff R